Products
IDOC introduces new Clerra ophthalmic lens range
First product under the IDOC Labs portfolio streamlines the lens selection process while covering 90% of dispensing needs, cutting lab costs by 25%, and boosting capture rates.
Events
ARVO 2026 signals a turning point for retina innovations
Highlights from this year’s research in vision and ophthalmology meeting covered genetics, gene editing, AI, advanced imaging, and more.
Events
Registration opens for Eyes On Glaucoma 2026
The largest virtual glaucoma event of the year offers up to 5 hours of free CE from leading clinical experts in the industry.
Business
Bayer to acquire Perfuse Therapeutics, expanding ophthalmic pipeline
Deal includes the biotech’s investigational sustained-release implant currently in phase 2 clinical trials for glaucoma and diabetic retinopathy.
Pipeline
New SightGlass 24-month data shows DOT lenses significantly slow pediatric myopia progression
Unveiled at ARVO 2026, DOT lenses saved more than 1 D of myopic progression on average after 2 years among 6-to-10-year-old wearers.
Research
Breakthrough trial finds MiYOSMART iQ spectacle lenses halt childhood myopia progression
Latest 12-month data details highest myopia-control efficacy results reported to date in myopes as young as age 4 wearing HOYA’s D.I.M.S. technology.
Events
B+L Vision Care Summit spotlights contact lens and technology advancements
Clinicians share insights on dry eye care, contact lens adoption, and patient-centered treatment approaches.
Research
Are blue-light blocking IOLs actually effective?
Yellow-tinted lenses were associated with a decline in macular pigment density over 3 years, the opposite of the intended effect.
Business
Sun Pharma to buy Organon in $11.75B all-cash deal
Closing in early 2027, the acquisition will position the Indian pharma company as a leader in the global biosimilar, established brands / branded generic spaces.
Products
ARVO 2026: Heidelberg debuts new ophthalmic imaging and data management tech
Medtech company premiers still-investigational imaging platform with OCT, a fully digitally surgical microscope, and additions to the HEYEX 2 platform.
Business
Leadership watch: Updates from Nanoscope, Topcon, Tenpoint, and TheiaLife
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Products
Harrow's Iopidine earns J-Code for postop inflammation and pain
Effective July 1, ophthalmic solution will be reimbursable for in-office treatment after glaucoma and ophthalmic laser procedures.
Business
Visionix–Revenio and Halma-Surgistar deals drive eye care consolidation
Halma’s bolt-on acquisition of Surgistar targets expansion of its surgical portfolio while Revenio will add Visionix’s Optovue line of OCT.
Products
Avulux expands migraine lens portfolio with new photochromic and polarized options
Precision light-filtering approach introduces two lenses designed to block harmful light outdoors while adapting to changing environments.
Research
Epioxa phase 3 pivotal trial supports early intervention for keratoconus management
New findings reinforce epi-on CXL's role in early keratoconus treatment, Glaukos is planning an extension trial for long-term monitoring.
Events
Retina Summit 2026: DR referrals and genetic testing for ODs
AAO’s one-day meeting explored retina care’s shift from referral-based to decision-making at the OD level.
Business
CareCredit report highlights gap between patient demand and vision care financing access
National consumer study unveils costly barriers influencing patient decisions, prompting ECPs to initiate conversations early.
Research
Researchers question safety of red light among pediatric myopes
Laboratory analysis suggests some devices may exceed established retinal safety limits during recommended treatment times.
Events
Eyes On Eyecare and the Intrepid Eye Society launch new video channel
Inside Intrepid offers dynamic discussions and a rare, behind-the-scenes look at how top ODs approach and manage complex topics in clinical practice.
Products